Literature DB >> 1955305

Vogt-Koyanagi-Harada syndrome: clinical and instrumental contribution.

F Trebini1, A Appiotti, R Bacci, D Daniele, A Inglezis, G Scarzella.   

Abstract

Vogt-Koyanagi-Harada syndrome is a rare disease, which probably has a cell-mediated autoimmune pathogenesis, marked by ocular (anterior and/or posterior uveitis), dermatological (poliosis, canities, vitiligo) and neurological (meningo-encephalitis) disorders of variable severity in variable combinations. The clinical pattern in the case reported here showed severe neurological involvement (headache, ataxia and confusional state) followed by anteroposterior uveitis. Instrumental investigations (cerebrospinal fluid, VEPs, BAEPs, EEG, CT and MRI brainscans) confirmed the diagnosis. The response to cortisone therapy was excellent. We emphasize the importance of the neuroradiological investigations, because of their peculiarities, and review the reports of cases with marked meningo-encephalitic impairment, given the dearth of reports in the neurological journals.

Entities:  

Mesh:

Year:  1991        PMID: 1955305     DOI: 10.1007/bf02335510

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  16 in total

1.  [Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author's transl)].

Authors:  S Sugiura
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1976-11-10

2.  VIRUSLIKE INCLUSION BODIES IN SUBRETINAL FLUID IN UVEO-ENCEPHALITIS.

Authors:  T F SCHLAEGEL; W R MORRIS
Journal:  Am J Ophthalmol       Date:  1964-12       Impact factor: 5.258

3.  UVEOMENINGOENCEPHALITIC SYNDROME (VOGT-KOYANAGI-HARADA).

Authors:  E M PATTISON
Journal:  Arch Neurol       Date:  1965-02

4.  [Uveo-meningitis, uveo-encephalitis: Vogt-Koyanagi-Harada syndrome. Intracranial pseudohypertension. Report of 3 cases].

Authors:  A VAZQUEZ LEYVA
Journal:  Arch Hosp Univ       Date:  1959 Jul-Aug

5.  The uveo-encephalitic syndrome or Vogt-Koyanagi-Harada disease.

Authors:  H REED; A LINDSAY; J L SILVERSIDES; J SPEAKMAN; G MONCKTON; D L REES
Journal:  Can Med Assoc J       Date:  1958-09-15       Impact factor: 8.262

6.  [Vogt-Koyanagi-Harada disease. Description of a case].

Authors:  P Puiatti; C Aleci; S D'Amelio; E Gremmo; A Demarie; M Goitre
Journal:  G Ital Dermatol Venereol       Date:  1987-06       Impact factor: 2.011

7.  [Current aspects of the Vogt-Koyanagi-Harada syndrome. Apropos of 9 cases].

Authors:  S Limon; P Girard; E Bloch-Michel; L Guillevin; A Forest
Journal:  J Fr Ophtalmol       Date:  1985       Impact factor: 0.818

8.  Halo nevi and the Vogt-Koyanagi-Harada syndrome. Manifestations of vitiligo.

Authors:  J J Nordlund; D Albert; B Forget; A B Lerner
Journal:  Arch Dermatol       Date:  1980-06

9.  Harada's disease and Vogt-Koyanagi syndrome; uveoencephalitis.

Authors:  A R COWPER
Journal:  AMA Arch Ophthalmol       Date:  1951-04

10.  Vogt-Koyanagi-Harada syndrome with focal neurologic signs.

Authors:  J R Lubin; J I Loewenstein; A R Frederick
Journal:  Am J Ophthalmol       Date:  1981-03       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.